ADVANCED TECHNOLOGY INTERNATIONAL - OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM
Key Details
Description
OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM
Context & Analysis
On Mar 4, 2026, Department of Health and Human Services obligated $303,999,997 to ADVANCED TECHNOLOGY INTERNATIONAL for other transaction: production of drug substances and drug products at commercial scale under biomap-consortium. The award is classified under NAICS 325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in SUMMERVILLE, SC. The contract is scheduled through Mar 1, 2030. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325414 — related awards are listed below.
Contractor Information
Similar Awards
DEVELOPMENT AND DOMESTIC MANUFACTURE OF ADJUVANTED, PANDEMIC INFLUENZA VACCINES
SANOFI VACCINES US INC.
$612.2M
EXPANSION OF PRODUCTION CAPACITY OF MAN-MADE FABRIC FOR MANUFACTURING DISPOSABLE MEDICAL GOWNS
ADVANCED TECHNOLOGY INTERNATIONAL
$248.5M
OTHER TRANSACTION: PROCUREMENT AND SUSTAINMENT OF N95 MASK MANUFACTURING CAPACITY UNDER THE BIOMAP-CONSORTIUM.
ADVANCED TECHNOLOGY INTERNATIONAL
$141.3M
EXPANSION OF DOMESTIC MANUFACTURING CAPACITY FOR NITRILE GLOVES
ADVANCED TECHNOLOGY INTERNATIONAL
$61.0M
MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE
SANOFI VACCINES US INC.
$53.2M
Stay Updated
Get notified about new opportunities matching your interests.